GLICLAZIDE 60 MG MR TABLETS (Leaflet) Scheme Rec.INN ATC (Anatomical Therapeutic Chemical Classification) A10BB09 CAS registry number (Chemical Abstracts Service) 0021187-98-4 Chemical Formula C15-H21-N3-O3-S Molecular Weight 323 Therapeutic Category ...
of glycemic response of breakable fixed dose combination (FDC) of gliclazide 60mg + metformin 500mg in 759 Indian patients with T2DM showed that 33.2% of patients achieved glycemic control with one tablet, 50% with one and half tablets and 77.5% with two tablets (Kalra and Das, 2017)...
DRUG tabletsDRUG dosageACCURACYObjective: A new spectrophotometric method for the gliclazide quantitation in dosage forms has been developed Material and Method: The subjects of the study were modified-release tablets ("Diaglizide" 80 mg, "Diaglizide MR" 60 mg, "Diaglizide MR" 30 m...
of glycemic response of breakable fixed dose combination (FDC) of gliclazide 60mg + metformin 500mg in 759 Indian patients with T2DM showed that 33.2% of patients achieved glycemic control with one tablet, 50% with one and half tablets and 77.5% with two tablets (Kalra and Das, 2017)...
Conventional gliclazide tablets produce poor and erratic bioavailability, irreproducible therapeutic response, need frequent administration of a large amount of oral dose in T2DM, due to its low solubility in the stomach and variable absorption in the intestine. A conventional gliclazide oral dosage form...
Bioequivalence study of gliclazide sustained release tablets; 格列齐特缓释片的人体生物等效性 3. Methods 120 patients,with type Ⅱ diabetes were randomly assigned to Control and treatment groups,the control group(n=60)receive Gliclazide Sustained Release Tablets plus Acarbose Tablets for 10 weeks,and...
Bioequivalence study of gliclazide sustained release tablets; 格列齐特缓释片的人体生物等效性 3. Methods 120 patients,with type Ⅱ diabetes were randomly assigned to Control and treatment groups,the control group(n=60)receive Gliclazide Sustained Release Tablets plus Acarbose Tablets for 10 weeks,and...